For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Axcella Health Inc.

USPTO Granted Patents = 25

EPO Patents = 1

Trademarks = 5

Forward Citations = 168

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Michael Hamill (21 out of 22 patents)

David Arthur Berry (11 out of 84 patents)

Raffi Afeyan (11 out of 11 patents)

4. Nathaniel Silver (9 out of 13 patents)

5. Geoffrey Von Maltzahn (8 out of 101 patents)

6. John Kramarczyk (7 out of 7 patents)

7. Brett Adam Boghigian (7 out of 15 patents)

8. William Comb (6 out of 6 patents)

9. Chung-Wei Lee (5 out of 5 patents)

10. Rajeev Chillakuru (5 out of 8 patents)

11. Sean Carroll (5 out of 39 patents)

12. Harry Luithardt (4 out of 4 patents)

13. Ying-Ja Chen (3 out of 3 patents)

14. Matthew Russell (3 out of 3 patents)

15. Caitlyn Harvey (2 out of 2 patents)

25 patents: Sort by Forward Citations

1. 11833127 - Compositions and methods for the treatment of fat infiltration in muscle (2023-12-05),

2. 11737999 - Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19 (2023-08-29),

3. 11679089 - Methods of manufacturing amino acid compositions (2023-06-20),

4. 11617731 - Amino acid compositions and their use for the treatment of traumatic brain injury (2023-04-04),

5. 11602511 - Amino acid compositions and methods for the treatment of liver diseases (2023-03-14),

6. 11571404 - Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting (2023-02-07),

7. 11357824 - Nutritive polypeptides and formulations thereof, and methods of production and use thereof (2022-06-14),

8. 11298332 - Compositions for therapy and health containing amino acids with bitter taste (2022-04-12),

9. 11129804 - Amino acid compositions and methods for the treatment of liver diseases (2021-09-28),

10. 11058654 - Compositions and methods for the treatment of hemoglobinopathies and thalassemias (2021-07-13),

11. 10973793 - Compositions and methods for the treatment of fat infiltration in muscle (2021-04-13),

12. 10682325 - Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting (2020-06-16),

13. 10660870 - Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting (2020-05-26),

14. 10596136 - Compositions and methods for the treatment of fat infiltration in muscle (2020-03-24),

15. 10471034 - Amino acid compositions and methods for the treatment of liver diseases (2019-11-12),

Axcella Health Inc. is a biotechnology company focused on the development of novel therapeutics that harness the power of endogenous metabolic modulators (EMMs) to address a range of complex diseases. Using its proprietary EMM platform, Axcella is dedicated to discovering and developing innovative treatments for liver and muscle-related disorders, as well as various metabolic conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

25 Patents

#93 in Cambridge, MA

#776 in Massachusetts

#12,940 in US

#24,961 in the World

Cambridge, MA, United States of America

Axcella Health Inc.

Forward Citations = 168

41 inventors:

Michael Hamill (21 out of 22 patents)

David Arthur Berry (11 out of 84 patents)

Raffi Afeyan (11 out of 11 patents)

4. Nathaniel Silver (9 out of 13 patents)

5. Geoffrey Von Maltzahn (8 out of 101 patents)

Please report any incorrect information to support@idiyas.com

Loading…